Page 1

IDEXX FOR IMMEDIATE RELEASE Contact : John Ravis , Investor Relations , 1-207-556-8155 IDEXX Laboratories Announces Second Quarter Results Achieves reported revenue growth of 30 % and organic revenue growth of 25 % , driven by CAG Diagnostics recurring revenue growth of 30 % as reported and 26 % organic Delivers EPS of $ 2.34 , representing 36 % growth as reported and 33 % on a comparable basis Increases 2021 revenue guidance to $ 3,170 million - $ 3,205 million , reflecting higher expectations for reported growth of 17 % - 18.5 % and organic growth of 14.5 % -16 % , supported by projected CAG Diagnostics recurring revenue growth of 18 % - 19.5 % as reported and 16 % - 17.5 % organic Raises 2021 EPS outlook to $ 8.20 - $ 8.36 , reflecting an increase of 1 % - 1.5 % in the organic revenue growth outlook and expectations for higher operating margins of 28.6 % - 29.1 % WESTBROOK , Maine , July 30 , 2021— IDEXX Laboratories , Inc. ( NASDAQ : IDXX ) , a global leader in veterinary diagnostics , veterinary practice software and water microbiology testing , today announced second quarter results , as well as an update on U.S. companion animal diagnostics sector trends . Second Quarter Results The Company reports revenues of $ 826 million for the second quarter of 2021 , an increase of 30 % as reported and 25 % organically . Second quarter results were driven by Companion Animal Group ( " CAG " ) Diagnostics recurring revenue growth of 30 % reported and 26 % organic , reflecting continued high gains in the U.S. and internationally , as well as 86 % reported and 78 % organic growth in CAG Diagnostics capital instrument revenue . Overall revenue growth was also supported by 32 % reported and 27 % organic revenue growth in the Water business . Earnings per diluted share ( " EPS " ) of $ 2.34 for the second quarter was supported by solid operating margin gains despite comparisons to highly controlled cost levels in the prior year . Overall operating margins expanded 110 basis points on an as reported and comparable basis . EPS results also benefited from a higher than expected $ 0.07 per share in tax benefits from share - based compensation .